Comments

Enveric Biosciences

ENVBNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.530000
0.0612.77%
Pre-Market: 8:52 AM EDT
15 minutes delayed

Enveric Biosciences (ENVB) Forecast

NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Enveric Biosciences (NASDAQ:ENVB) Stock Quotes, Forecast and News Summary

Enveric Biosciences Stock (NASDAQ: ENVB) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.107.99K / 537.25K
Day Range- - -
52 Wk Range0.41 - 3.90
Market Cap$4.22M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
42
Short Interest
1.93%
Days to Cover1.29

Recent News

'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
Enveric Biosciences reported on Wednesday financial results for the first quarter of 2024 ended March 31, 2024."We believe the first quarter of 2024 was a highly productive period for Enveric as the company continued to advance the development of the lead neuroplastogen drug candidate, EB-003, in preparation for an investigational new drug (IND) application and the expected initiation of a planned clinical development program," Joseph Tucker, Ph.D., director and CEO of Enveric, said. "EB-003 was designed specifically to address this major safety profile deficiency in the first-generation psychedelic approach to treating neuropsychiatric illness, and we are excited to advance its development."
Jelena Martinovic

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Enveric Biosciences Inc
Sector
Health Care
Industry
Pharmaceuticals
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplasto...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ENVB
CING

FAQ

Q

How do I buy Enveric Biosciences (ENVB) stock?

A

You can purchase shares of Enveric Biosciences (NASDAQ:ENVB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Enveric Biosciences (ENVB) competitors?

A

Other companies in Enveric Biosciences’s space includes: Cingulate (NASDAQ:CING), Biofrontera (NASDAQ:BFRI), Processa Pharma (NASDAQ:PCSA), NovaBay Pharmaceuticals (AMEX:NBY) and Titan Pharma (NASDAQ:TTNP).

Q

What is the target price for Enveric Biosciences (ENVB) stock?

A

There is no analysis for Enveric Biosciences.

Q

What is the forecast for Enveric Biosciences (ENVB) stock?

A

Enveric Biosciences has a consensus price target of $3.82.

Q

Current stock price for Enveric Biosciences (ENVB)?

A

The stock price for Enveric Biosciences (NASDAQ: ENVB) is $0.53 last updated Today at July 22, 2024 at 8:52 AM EDT.

Q

Does Enveric Biosciences (ENVB) pay a dividend?

A

There are no upcoming dividends for Enveric Biosciences.

Q

When is Enveric Biosciences (NASDAQ:ENVB) reporting earnings?

A

Enveric Biosciences’s Q2 earnings are confirmed for Friday, August 9, 2024.

Q

Is Enveric Biosciences (ENVB) going to split?

A

There is no upcoming split for Enveric Biosciences.

Q

What sector and industry does Enveric Biosciences (ENVB) operate in?

A

Enveric Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch